PL326695A1 - Derivatives of stimulating aminoacids - Google Patents

Derivatives of stimulating aminoacids

Info

Publication number
PL326695A1
PL326695A1 PL96326695A PL32669596A PL326695A1 PL 326695 A1 PL326695 A1 PL 326695A1 PL 96326695 A PL96326695 A PL 96326695A PL 32669596 A PL32669596 A PL 32669596A PL 326695 A1 PL326695 A1 PL 326695A1
Authority
PL
Poland
Prior art keywords
aminoacids
stimulating
derivatives
stimulating aminoacids
Prior art date
Application number
PL96326695A
Other languages
English (en)
Inventor
James Allen Monn
Matthew John Valli
Steven Marc Massey
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605434.1A external-priority patent/GB9605434D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL326695A1 publication Critical patent/PL326695A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL96326695A 1995-11-16 1996-11-12 Derivatives of stimulating aminoacids PL326695A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US686495P 1995-11-16 1995-11-16
GBGB9605434.1A GB9605434D0 (en) 1996-03-15 1996-03-15 Excitatory amino acid derivatives

Publications (1)

Publication Number Publication Date
PL326695A1 true PL326695A1 (en) 1998-10-26

Family

ID=26308935

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96326695A PL326695A1 (en) 1995-11-16 1996-11-12 Derivatives of stimulating aminoacids

Country Status (22)

Country Link
EP (1) EP0774461B1 (xx)
KR (1) KR19990067598A (xx)
CN (1) CN1202167A (xx)
AR (2) AR004602A1 (xx)
AT (1) ATE319685T1 (xx)
AU (1) AU703409B2 (xx)
BR (1) BR9611511A (xx)
CA (1) CA2237910C (xx)
CO (1) CO4770955A1 (xx)
CZ (1) CZ150198A3 (xx)
DE (1) DE69635886T2 (xx)
EA (1) EA001617B1 (xx)
ES (1) ES2258771T3 (xx)
HU (1) HUP9903459A3 (xx)
IL (1) IL124487A (xx)
NO (1) NO982202L (xx)
NZ (1) NZ323205A (xx)
PE (1) PE17798A1 (xx)
PL (1) PL326695A1 (xx)
TR (1) TR199800877T2 (xx)
WO (1) WO1997018199A1 (xx)
YU (1) YU60796A (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998032436A1 (en) * 1997-01-29 1998-07-30 Eli Lilly And Company Treatment for premenstrual dysphoric disorder
US6825211B1 (en) 1997-07-18 2004-11-30 Georgetown University Bicyclic metabotropic glutamate receptor ligands
US6204292B1 (en) 1997-07-18 2001-03-20 Georgetown University Bicyclic metabotropic glutamate receptor ligands
DE19801646A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte alpha,beta-annellierte Butyrolactone
DE19801636A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte bicyclische Lactone
DE19801648A1 (de) * 1998-01-17 1999-07-22 Bayer Ag alpha-Substituierte Lactone
DE19801647A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte beta,gamma-annellierte Lactone
GB2355982A (en) * 1999-11-03 2001-05-09 Lilly Co Eli Heterocyclic amino acids
TW200833674A (en) * 2002-06-11 2008-08-16 Lilly Co Eli Prodrugs of excitatory amino acids
CN102216243B (zh) * 2008-11-14 2014-09-03 Dsm精细化学奥地利Nfg两合公司 制备环丙烷衍生物的方法
WO2010111080A2 (en) 2009-03-27 2010-09-30 Eli Lilly And Company Optimized treatment of schizophrenia
US8735397B2 (en) 2010-03-29 2014-05-27 Vanderbilt University Method for treating schizophrenia and related diseases
WO2012173850A1 (en) 2011-06-17 2012-12-20 Eli Lilly And Company Bicyclo (3.1.0) hexane- 2, 6 -dicarboxylic acid derivatives as mglu2 receptor agonist
AR089718A1 (es) 2012-02-01 2014-09-10 Lilly Co Eli AGONISTAS DE mGlu2/3
DK3096790T3 (da) 2014-01-21 2019-10-07 Janssen Pharmaceutica Nv Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse
DK3431106T3 (da) * 2014-01-21 2021-03-15 Janssen Pharmaceutica Nv Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2572842A (en) * 1947-08-05 1951-10-30 Du Pont The n-carboanhydride of 2-amino-4, 6, 6-trimethylheptanoic acid and polymers therefrom
US4536330A (en) * 1982-09-23 1985-08-20 International Flavors & Fragrances Inc. 1-Hydroxymethyl-2-acyl cyclopropane derivatives and esters and cyclic condensation products thereof, organoleptic uses of same and processes for preparing same
WO1996004901A1 (en) * 1994-08-12 1996-02-22 Eli Lilly And Company Composition and method for treating anxiety
EP0776200A4 (en) * 1994-08-12 2001-01-17 Lilly Co Eli AGENT AND METHOD FOR PROTECTING DRUG ADDICTION
PL182285B1 (pl) * 1994-08-12 2001-12-31 Lilly Co Eli Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL

Also Published As

Publication number Publication date
AR006748A1 (es) 1999-09-29
ES2258771T3 (es) 2006-09-01
EA001617B1 (ru) 2001-06-25
YU60796A (sh) 1998-12-23
NO982202D0 (no) 1998-05-14
PE17798A1 (es) 1998-04-18
CN1202167A (zh) 1998-12-16
CO4770955A1 (es) 1999-04-30
ATE319685T1 (de) 2006-03-15
NO982202L (no) 1998-05-14
CZ150198A3 (cs) 1998-10-14
HUP9903459A3 (en) 2001-08-28
DE69635886T2 (de) 2006-10-19
EA199800377A1 (ru) 1998-10-29
AU703409B2 (en) 1999-03-25
EP0774461A1 (en) 1997-05-21
IL124487A0 (en) 1998-12-06
KR19990067598A (ko) 1999-08-25
IL124487A (en) 2001-01-11
AU7727996A (en) 1997-06-05
DE69635886D1 (de) 2006-05-04
CA2237910C (en) 2005-12-27
EP0774461B1 (en) 2006-03-08
TR199800877T2 (xx) 1998-09-21
BR9611511A (pt) 1999-05-04
NZ323205A (en) 1999-06-29
HUP9903459A2 (hu) 2001-04-28
AR004602A1 (es) 1998-12-16
CA2237910A1 (en) 1997-05-22
WO1997018199A1 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
PL323066A1 (en) Derivatives of quinazoline
PL313541A1 (en) Derivatives of quinazoline
PL311736A1 (en) Derivatives of 1h-imidazoles
PL321326A1 (en) Derivative of guanidine
PL327998A1 (en) Novel derivatives of 19-nor-pregnene
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
IL111122A0 (en) Methods of stimulating phagocytosis
GB9526560D0 (en) Use of 2-Amino-Heterocycles
IL118294A0 (en) Preparation of 4-aryl-piperidine derivatives
HUP9800731A3 (en) Stimulation of meiosis
PL326695A1 (en) Derivatives of stimulating aminoacids
PL322084A1 (en) Derivatives of indole
IL122607A0 (en) Preparation of N-substituted 3-hydroxypyrazoles
IL116924A0 (en) Preparation of n-aryl- and n-hetarylhydroxylamines
PL326491A1 (en) Novel method of obtaining derivatives of phenylimidazolydine
PL327238A1 (en) Derivatives of cyclopeptides
IL122338A0 (en) Methods of inhibiting phagocytosis
ZA96725B (en) Use of phenyclyclohexylcarboxamides
PL322721A1 (en) Derivatives of benzimidazole
HUP9802589A3 (en) Bone stimulating factor
PL326080A1 (en) Short forms of chemokin beta-8
ZA95694B (en) Novel derivatives of tetramethylcyclopropane
PL312544A1 (en) Derivatives of 4-marcaptobenzoyl guanidine
IL117786A (en) Preparation of alpha-bisoximes